Article citationsMore>>
Dondero, A., Pastorino, F., Della Chiesa, M., Corrias, M.V., Morandi, F., Pistoia, V., et al. (2016) PD-L1 Expression in Metastatic Neuroblastoma as an Additional Mechanism for Limiting Immune Surveillance. Oncoimmunology, 5, e1064578.
https://doi.org/10.1080/2162402X.2015.1064578
has been cited by the following article:
-
TITLE:
N-Myc Inhibition: Advances in Neuroblastoma Treatment
AUTHORS:
Md Kamrul Hasan
KEYWORDS:
Neuroblastoma, N-Myc, PI3K/mTOR, PARP1, PD-L1, HAUSP
JOURNAL NAME:
CellBio,
Vol.6 No.3,
September
30,
2017
ABSTRACT: Neuroblastoma (NBL) is one
of the most common solid tumors and around 15% of cancer mortality in children.
Amplification of the N-Myc proto-oncogene is strongly correlated with
advanced disease and poor clinical outcome in NBL. Recent studies described
that ubiquitin-specific protease 7 (USP7; also known as HAUSP) interacts with
N-Myc, induces deubiquitination and subsequent stabilization of N-Myc that
in-turn potentiates N-Myc
function, and treatment with the HAUSP inhibitor (P22077) blocked such effects.
Related Articles:
-
Zedong Cheng, Na Li, Liming Hou, Kunling Jiao, Wenfei Wu
-
Djibril Samaké, Youssouf Sidibé, Sinaly Thiocary, Fatogoma Issa Koné, Youma Mamadou Maïga, Fatoumata Konaté, Yatemelou Dara, Kadidiatou Singaré, Abdoul Wahab Haidara, Adama Dembele, Djeneba Sacko, Mamadou Traoré, Boubacar Sanogo, Samba Karim Timbo, Mohamed Amadou Kéïta, Alhousseini Ag Mohamed
-
Antonin Kanfon, Dominique Lambert Lambert
-
Fanny Lapointe, Michael Stiffel, Jean-Philippe Auger, Marek Rola-Pleszczynski, Jana Stankova
-
Gayatri S. Gurjar, Ashok P. Giri, Vidya S. Gupta